Iridex swings to a fourth-quarter loss; shares fall

GabrielMadway

SAN FRANCISCO (MarketWatch) -- Iridex Corp.
IRIX, -2.10%
shares fell 15% to $7.53 in Tuesday morning trade after the Mountain View, Calif.-based company reported a fourth-quarter net loss of $3.77 million, or 48 cents a share, compared with a net profit of $381,000, or 5 cents a share, in the year-ago period. Revenue fell to $9.04 million from $10.4 million last year. Iridex is a provider of laser systems, disposable laser probes and delivery devices to treat eye diseases and skin diseases.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.